Arch Coal Inc (NYSE:ACI) has been given a consensus rating of “Hold” by the eighteen brokerages that are presently covering the company, AnalystRatingsNetwork.com reports. Five research analysts have rated the stock with a sell rating, eight have issued a hold rating and three have issued a buy rating on the company. Arch Coal Inc (NYSE:ACI)…
Tata Communications (NASDAQ:TCL) enhanced connectivity enables the production team to have two multi-view video feeds for raw footage and a reverse data path, allowing them to operate a robotic trackside camera for the best possible race coverage. It gives the team access to quality footage, without the need to transport equipment and staff to each…
Citigroup Inc. reissued their sell rating on shares of AK Steel Holding (NYSE:AKS) in a research report released on Thursday morning. Citigroup Inc. currently has a $2.00 price objective on the stock, down from their previous price objective of $2.30. AK Steel Holding Corporation (NYSE:AKS) belongs to Basic Materials sector. Its net profit margin is…
Facebook Inc (NASDAQ:FB)’s New Year Resolution: More Video Ads in News Feed. The amount of video on Facebook Inc.’s news feed more than tripled last year, as many users and advertisers discovered the option for the first time. How much bigger video will get on the social network depends largely on Fidji Simo. Facebook Inc…
Jefferies Group reaffirmed their hold rating on shares of Blucora (NASDAQ:BCOR) in a report released on Thursday. Jefferies Group currently has a $15.00 price objective on the stock, down from their previous price objective of $17.00. Blucora, Inc. (NASDAQ:BCOR) belongs to Technology sector. Its net profit margin is 4.90% and weekly performance is -3.97%. On…
Actavis PLC (NYSE:ACT) agreed to pay about $66 billion for Allergan Inc., the maker of the antiwrinkle treatment Botox, in the year’s biggest pharmaceutical deal. The cash-and-stock purchase, in which Actavis will pay $219 a share, also puts an end to Valeant Pharmaceuticals International Inc.’s months-long hostile takeover fight for Allergan, a move backed by…
